WuXi Apptec Taps Altasciences to Support IND Platform
By Maggie Lynch
Altasciences will work with WuXi AppTec to support its investigational new drug platform designed to manage and accelerate IND applications.
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.